Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza

Estimados colegas , aquì les dejo las recomendaciones para el tratamiento y quimioprofilaxis de influenza.

Publicadas en Enero 21 del 2011.

Saludos 

Dr. Carlos Erazo

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6001a1.htm?s_cid=rr6001a1_x

"Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Recommendations and Reports

January 21, 2011 / 60(RR01);1-24

This report updates previous recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and treatment of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2008;57[No. RR-7]).This report contains information on treatment and chemoprophylaxis of influenza virus infection and provides a summary of the effectiveness and safety of antiviral treatment medications. Highlights include recommendations for use of 1) early antiviral treatment of suspected or confirmed influenza among persons with severe influenza (e.g., those who have severe, complicated, or progressive illness or who require hospitalization); 2) early antiviral treatment of suspected or confirmed influenza among persons at higher risk for influenza complications; and 3) either oseltamivir or zanamivir for persons with influenza caused by 2009 H1N1 virus, influenza A (H3N2) virus, or influenza B virus or when the influenza virus type or influenza A virus subtype is unknown; 4) antiviral medications among children aged <1 year; 5) local influenza testing and influenza surveillance data, when available, to help guide treatment decisions; and 6) consideration of antiviral treatment for outpatients with confirmed or suspected influenza who do not have known risk factors for severe illness, if treatment can be initiated within 48 hours of illness onset. Additional information is available from CDC's influenza website at http://www.cdc.gov/flu, including any updates or supplements to these recommendations that might be required during the 2010--11 influenza season. Health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information. Recommendations related to the use of vaccines for the prevention of influenza during the 2010--11 influenza season have been published previously (CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices [ACIP], 2010. MMWR 2010;59[No. RR-8]). "

Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical Considerations in the Conduct and Reporting of Research: Authorship and Contributorship

 Buenos días, estimados compañeros, estoy dejando para su lectura, las normas internacionales para ser considerados autores de un trabajo de investigación, artículo científico y guias.

Pueden leer màs en el link que se encuentra al final de este texto, les coloqué el link a las normas internacionales de publicación que ustedes pueden visitar.

Saludos

Dr. Carlos Erazo

"An “author” is generally considered to be someone who has made substantive intellectual contributions to a published study, and biomedical authorship continues to have important academic, social, and financial implications (1). An author must take responsibility for at least one component of the work, should be able to identify who is responsible for each other component, and should ideally be confident in their co-authors’ ability and integrity. In the past, readers were rarely provided with information about contributions to studies from persons listed as authors and in Acknowledgments (2). Some journals now request and publish information about the contributions of each person named as having participated in a submitted study, at least for original research. Editors are strongly encouraged to develop and implement a contributorship policy, as well as a policy on identifying who is responsible for the integrity of the work as a whole.
While contributorship and guarantorship policies obviously remove much of the ambiguity surrounding contributions, they leave unresolved the question of the quantity and quality of contribution that qualify for authorship. The ICJME has recommended the following criteria for authorship; these criteria are still appropriate for journals that distinguish authors from other contributors"


http://www.icmje.org/ethical_1author.html

Discrimination against people with HIV persists in China

Estimados amigos este es un editorial que salió en LANCET el día de hoy sobre la discriminación en personas VIH positiva.

 China has been praised in the past for addressing stigma surrounding HIV/AIDS. But a new report
shows that the country actually has a long way to go on this issue. Talha Khan Burki reports.

http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673611600792.pdf

Saludos

Dr. Carlos Erazo

Bibliotecas Virtuales gratuitas en España y On line

Estimados colegas, les dejo aquì el link para que ustedes se inscriban gratuitamente en FISTERRAE, http://www.fisterra.com/fisterrae/

	Fisterrae es una herramienta avanzada que integra recursos de apoyo en el punto de atención para profesionales sanitarios. Fisterrae combina: Una base de conocimientos clínicos con documentos actualizados, listos para ser usados como ayuda para tomar decisiones y desarrollados basándose en las evidencias científicas más recientes Una guía fármaco terapéutica con más de 1000 fichas Una calculadora clínica con mas de 60 funciones (Calcumed+) Una aplicación de apoyo a los puntos de vacunación con la que podrás elaborar calendarios vacunales personalizados (Calcuvac) Una colección de imágenes Algoritmos para consulta rápida
Está elaborada por un grupo de médicos y farmacéuticos y se actualiza permanentemente mediante la monitorización de más de 100 revistas médicas de mayor impacto y relevancia, de las revisiones de la Cochrane Library y de las más importantes bases de guías de práctica clínica. Para la elaboración de los documentos clínicos se utilizan artículos originales y con más frecuencia fuentes secundarias elaboradas con metodología fiable.

Este es el link para las bibliotecas visrtuales , una vez que ustedes se hayan inscrito en FISTERRAe.


http://www.fisterra.com/recursos_web/mapa.asp

Saludos

Dr. Carlos Erazo